Literature DB >> 15122917

Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8.

François Bigonnesse1, Sébastien A Lévesque, Filip Kukulski, Joanna Lecka, Simon C Robson, Maria J G Fernandes, Jean Sévigny.   

Abstract

A novel mammalian plasma membrane bound nucleoside triphosphate diphosphohydrolase (NTPDase), named NTPDase8, has been cloned and characterized. Analysis of cDNA reveals an open reading frame of 1491 base pairs encoding a protein of 497 amino acid residues with an estimated molecular mass of 54650 Da and a predicted isoelectric point of 5.94. In a mouse, the genomic sequence is located on chromosome 2A3 and is comprised of 10 exons. The deduced amino acid sequence reveals eight putative N-glycosylation sites, two transmembrane domains, five apyrase-conserved regions, and 20-50% amino acid identity with other mammalian NTPDases. mRNA expression was detected in liver, jejunum, and kidney. Both intact cells and crude cell lysates from COS-7 cells expressing NTPDase8 hydrolyzed P2 receptor agonists, namely, ATP, ADP, UTP, and UDP, but did not hydrolyze AMP. There was an absolute requirement for divalent cations for the catalytic activity (Ca(2+) > Mg(2+)) with an optimal pH between 5.5 and 8.0 for ATP and 6.4 for ADP hydrolysis. Kinetic parameters derived from analysis of crude cell lysates showed that the enzyme had lower apparent K(m) values for adenine nucleotides and for triphosphonucleosides (K(m,app) of 13 microM for ATP, 41 microM for ADP, 47 microM for UTP, and 171 microM for UDP). Hydrolysis of triphosphonucleosides resulted in a transient accumulation of the corresponding diphosphonucleoside, as expected from the apparent K(m) values. Enzymatic properties of NTPDase8 differ from those of other NTPDases suggesting an alternative way to modulate nucleotide levels and consequently P2 receptor activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122917     DOI: 10.1021/bi0362222

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Expression of ecto-ATPase NTPDase2 in human dental pulp.

Authors:  X Liu; L Yu; Q Wang; J Pelletier; M Fausther; J Sévigny; H S Malmström; R T Dirksen; Y F Ren
Journal:  J Dent Res       Date:  2011-12-14       Impact factor: 6.116

2.  Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5'-nucleotidase/CD73 in rat lymphocytes.

Authors:  Emilene B S Scherer; Luiz Eduardo B Savio; Fernanda C Vuaden; Andréa G K Ferreira; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

Review 3.  Nucleotide signaling in nervous system development.

Authors:  Herbert Zimmermann
Journal:  Pflugers Arch       Date:  2006-04-25       Impact factor: 3.657

4.  Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds.

Authors:  Dianna L Bartel; Susan L Sullivan; Elise G Lavoie; Jean Sévigny; Thomas E Finger
Journal:  J Comp Neurol       Date:  2006-07-01       Impact factor: 3.215

Review 5.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment.

Authors:  Agnes Kittel; Beata Sperlágh; Julie Pelletier; Jean Sévigny; Terence L Kirley
Journal:  Int J Dev Neurosci       Date:  2007-05-17       Impact factor: 2.457

Review 7.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

8.  Expression, purification and crystallization of the ecto-enzymatic domain of rat E-NTPDase1 CD39.

Authors:  Xiaotian Zhong; Madhavan Buddha; Guido Guidotti; Ron Kriz; Will Somers; Lidia Mosyak
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

9.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  Changes in E-NTPDase 3 expression and extracellular nucleotide hydrolysis during the myofibroblast/lipocyte differentiation.

Authors:  Cláudia M B Andrade; Márcia R Wink; Rogério Margis; Radovan Borojevic; Ana Maria O Battastini; Fátima C R Guma
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.